efficacy of tirzepatide Alternative dosing regimens GLP-1 receptor agonists may reduce costs and maintain weight loss 10 Benefits of Tirzepatide

Mitchell, D

Through the end of safety follow-up in each trial, 0.6% of adults in each of the tirzepatide and placebo groups reported suicidal ideation, with most of these reports deemed low risk

462 (96%) patients in the semaglutide 20 mg group and 471 (98%) in the semaglutide 10 mg group completed the trial

Once a generic enters the market, the brand name vanishes

other GLP-1 medications may have different recommendations (check the specific product SmPC)

Ideal candidates for GLP-1 medical weight loss GLP-1 medications are often recommended for adults with a body mass index (BMI) over 30 or those with a BMI over 27 and weight-related health conditions such as hypertension or type 2 diabetes